U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606677) titled 'Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women' on May 06.
Brief Summary: This prospective, multicenter cohort study will recruit eligible HPV16/18-positive women from three tertiary hospitals in China. Peripheral blood samples and clinical data (cytology, HPV genotyping, colposcopy-directed biopsy) will be collected, followed by standardized mass cytometry (CyTOF) to develop and evaluate an immune model across cervical lesion grades.
Study Start Date: May 15
Study Type: OBSERVATIONAL
Condition:
CIN 2/3
Cervical Cancer (Early Detection)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Women'...